Overview

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Status:
Completed
Trial end date:
2018-11-30
Target enrollment:
Participant gender:
Summary
The study investigates the effect of 40IU of intranasal vasopressin on cooperative behavior in patients with schizophrenia
Phase:
N/A
Details
Lead Sponsor:
National Institute of Mental Health and Neuro Sciences, India
Treatments:
Arginine Vasopressin
Vasopressins